Literature DB >> 7383949

Hypercalcaemia in malignant lymphoma.

M Greaves, B W Hancock.   

Abstract

Three patients with malignant lymphoma complicated by hypercalaemia without radiological bone abnormality are described. The medical literature has been reviewed and the possible underlying mechansims discussed. The early diagnosis of this potentially fatal complication is important since this may respond (together with the underlying disease) to appropriate chemotherapy.

Entities:  

Mesh：

Year:  1980        PMID： 7383949      PMCID： PMC2425974          DOI： 10.1136/pgmj.56.651.34

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  27 in total

1.  Hypercalcemia in malignant disease without evidence of bone destruction.

Authors:  A GELLHORN; C H PLIMPTON
Journal:  Am J Med       Date:  1956-11       Impact factor: 4.965

2.  Hypercalcemia in Hodgkin's disease.

Authors:  B KABAKOW; F H KING; M F MINES
Journal:  N Engl J Med       Date:  1957-01-10       Impact factor: 91.245

3.  Prostaglandin-mediated hypercalcemia in the VX2 carcinoma-bearing rabbit.

Authors:  H W Seyberth; W C Hubbard; O Oelz; B J Sweetman; J T Watson; J A Oates
Journal:  Prostaglandins       Date:  1977-08

4.  Human breast tumour-induced osteolysis and prostaglandins.

Authors:  M Dowsett; G C Easty; T J Powles; D M Easty; A M Neville
Journal:  Prostaglandins       Date:  1976-03

5.  Hyperparathyroidism associated with malignant tumors of nonparathyroid origin.

Authors:  G S Omenn; S I Roth; W H Baker
Journal:  Cancer       Date:  1969-11       Impact factor: 6.860

6.  Bone-resorbing activity in supernatants from lymphoid cell lines.

Authors:  G R Mundy; R A Luben; L G Raisz; J J Oppenheim; D N Buell
Journal:  N Engl J Med       Date:  1974-04-18       Impact factor: 91.245

7.  Bone resorbing activity in supernatant fluid from cultured human peripheral blood leukocytes.

Authors:  J E Horton; L G Raisz; H A Simmons; J J Oppenheim; S E Mergenhagen
Journal:  Science       Date:  1972-09-01       Impact factor: 47.728

8.  Partial purification of osteoclast-activating factor from phytohemagglutinin-stimulated human leukocytes.

Authors:  R A Luben; G R Mundy; C L Trummel; L G Raisz
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

9.  Breast-cancer osteolysis, bone metastases, and anti-osteolytic effect of aspirin.

Authors:  T J Powles; M Dowsett; G C Easty; D M Easty; A M Neville
Journal:  Lancet       Date:  1976-03-20       Impact factor: 79.321

10.  IMMUNOCHEMICAL IDENTIFICATION OF PARATHYROID HORMONE IN NON-PARATHYROID NEOPLASMS ASSOCIATED WITH HYPERCALCEMIA.

Authors:  A H TASHJIAN; L LEVINE; P L MUNSON
Journal:  J Exp Med       Date:  1964-03-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.